The White House threatens to cancel the patents of taxpayer-funded drugs if they’re too expensive for patients to afford
The move follows a first-ever effort from the White House to negotiate what Medicare pays for medicines.
The move follows a first-ever effort from the White House to negotiate what Medicare pays for medicines. Read More
